拜瑞妥
医学
华法林
危险系数
心房颤动
冲程(发动机)
临床终点
内科学
置信区间
栓塞
麻醉
心脏病学
随机对照试验
外科
机械工程
工程类
作者
Manesh R. Patel,Kenneth W. Mahaffey,Jyotsna Garg,Guohua Pan,Daniel E. Singer,Werner Hacke,Günter Breithardt,Jonathan L. Halperin,Graeme J. Hankey,Jonathan P. Piccini,Richard C. Becker,Christopher C. Nessel,John F. Paolini,Scott D. Berkowitz,Keith A.A. Fox,Robert M. Califf
标识
DOI:10.1056/nejmoa1009638
摘要
The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin.
科研通智能强力驱动
Strongly Powered by AbleSci AI